Matthias Pinter

57PUBLICATIONS
167CO-AUTHORS
Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cardiology (incl. cardiovascular diseases)Haematological tumoursMetals and alloy materials
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (57)

|Aug 06, 2026
Circulating extracellular vesicles carrying PD-1, PD-L1 and CTLA-4 inform resistance to anti-PD-L1-based therapy in HCC.

|Jun 10, 2026
Trial design and end points in hepatocellular carcinoma: an EASL-AASLD-ILCA consensus statement.

|Jun 01, 2026
Summative Comorbidities Are Independently Associated With Mortality in Patients With Hepatocellular Carcinoma.

|May 19, 2026
Liver Transplantation After Immune Checkpoint Inhibition in Hepatocellular Carcinoma-Data From the Multinational LITCHI Registry.

|Jan 23, 2026
The Alpha-1 Pi*MZ Genotype Is an Independent Risk Factor for Hepatocellular Carcinoma Development in Patients With ACLD.

Lorenz Balcar, Georg Semmler, Bernhard Scheiner

|Nov 06, 2025
Indocyanine Green Clearance Correlates With Biomarkers Reflecting Key Disease-Driving Mechanisms in Advanced Chronic Liver Disease and Predicts Acute-on-Chronic Liver Failure and Death.

Mathias Jachs, Tânia Carvalho, Benedikt Simbrunner

Pageof 10

Frequent Collaborators

33 joint publications

Bernhard Scheiner

21 joint publications

Thomas Reiberger

17 joint publications

Lorenz Balcar

17 joint publications

Mattias Mandorfer